Mutation Status Matters: RAS, P53, and Targeting Autophagy as a Potential Strategy in NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2015.12.056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Of Autophagy and in Vivo Pancreatic Carcinogenesis: The P53 Status Matters!

Clinics and Research in Hepatology and Gastroenterology
HepatologyGastroenterology
2014English

Targeting EGFR-mediated Autophagy as a Potential Strategy for Cancer Therapy

International Journal of Cancer
Cancer ResearchOncology
2018English

Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis

Cells
2019English

P53 Expression and K-Ras Mutation in Colorectal Adenomas.

Gut
Gastroenterology
1993English

K-Ras and P53 Mutations in Association With COX-2 and Htert Expression and Clinico-Pathological Status of NSCLC Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2008English

Regulation of Autophagy by Polyphenolic Compounds as a Potential Therapeutic Strategy for Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

K-Ras Mutation Subtypes in NSCLC and Associated Co-Occuring Mutations in Other Oncogenic Pathways

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Targeting P53 as a General Tumor Antigen.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

High Metastatic Potential in Mice Inheriting a Targeted P53 Missense Mutation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy